The estimated Net Worth of Zackary S. Irani is at least $648 Tisíc dollars as of 25 May 2023. Mr. Irani owns over 700 units of Biomerica stock worth over $317,394 and over the last 12 years he sold BMRA stock worth over $0. In addition, he makes $330,481 as Chairman of the Board a Chief Executive Officer at Biomerica.
Zackary has made over 31 trades of the Biomerica stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 700 units of BMRA stock worth $1,113 on 25 May 2023.
The largest trade he's ever made was exercising 75,000 units of Biomerica stock on 17 November 2016 worth over $32,250. On average, Zackary trades about 4,860 units every 83 days since 2012. As of 25 May 2023 he still owns at least 1,020,560 units of Biomerica stock.
You can see the complete history of Mr. Irani stock trades at the bottom of the page.
Zackary S. Irani serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. Zackary Irani has been a Director of the Company, and has been serving as the Company's Chairman of the Board and Chief Executive Officer since April 29, 1997. Prior to that time, Mr. Irani served as the Company's Vice President of Business Development. He has been an employee of the Company since 1986. During fiscal 2008 and 2009, Mr. Irani also served as Chairman of the Board of Lancer Orthodontics, Inc. and served as Lancer's Chief Executive Officer from April 1997 until April 2004.
As the Chairman of the Board a Chief Executive Officer of Biomerica, the total compensation of Zackary Irani at Biomerica is $330,481. There are no executives at Biomerica getting paid more.
Zackary Irani is 54, he's been the Chairman of the Board a Chief Executive Officer of Biomerica since 1997. There are 7 older and 2 younger executives at Biomerica. The oldest executive at Biomerica Inc. is Francis Cano, 76, who is the Independent Director.
Zackary's mailing address filed with the SEC is 17571 Von Karman Ave, Irvine, CA 92614, USA.
Over the last 12 years, insiders at Biomerica have traded over $80,900 worth of Biomerica stock and bought 151,277 units worth $334,788 . The most active insiders traders include Mark A Sirgo, David Moatazedi a John P. Kenny. On average, Biomerica executives and independent directors trade stock every 61 days with the average trade being worth of $3,349. The most recent stock trade was executed by Zackary S. Irani on 25 May 2023, trading 700 units of BMRA stock currently worth $1,113.
biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company’s products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh
Biomerica executives and other stock owners filed with the SEC include: